Dr. Farrugia publishes “Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer”

Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.

Clark BZ, Farrugia DJ, Landmann A, Diego EJ, Dabbs DJ, Puhalla SL, Jankowitz RC, Brufsky AM, Ahrendt GM, McAuliffe PF, Bhargava R.

Am J Clin Pathol. 2018 Mar 7;149(4):332-343

 

Click the link below for full text of publication:

Daniel Farrugia MD PhD – Prognostic Significance of Modified Residual Disease in Breast Cancer

Leave a Reply

Your email address will not be published. Required fields are marked *